Study: MUSE System Reduces PPI Use in 85% of Patients

Share on Facebook
During the Society of American Gastrointestinal and Endoscopy Surgeons 2014 meeting, Medigus presented a study on its MUSE system.

The study examined the system's efficacy as a trans-oral treatment for gastroesophageal reflux disease. The study found:

•    85 percent of GERD patients reduced proton pump inhibitor use by 50 percent or more
•    Of these patients, 65 percent were able to eliminate medication use after six months
•    73 percent of patients reported improved quality of life scores of 50 percent or more

More Articles on Gastroenterology:
Adenoma Detection Rate: Lowering Colorectal Cancer Risk
12 Gastroenterologist Moves & Honors
Defining Leadership in the GI Field: 2 Gastroenterologists Discuss Their Strategies

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

18 gastroenterology-driven ASCs & facilities opened or announced in 2014

Read Now